Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
106M
-
Number of holders
-
127
-
Total 13F shares, excl. options
-
48.3M
-
Shares change
-
+1.61M
-
Total reported value, excl. options
-
$1.68B
-
Value change
-
+$59.9M
-
Put/Call ratio
-
0.26
-
Number of buys
-
49
-
Number of sells
-
-62
-
Price
-
$34.87
Significant Holders of Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share (RCUS) as of Q3 2021
152 filings reported holding RCUS - Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share as of Q3 2021.
Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share (RCUS) has 127 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.3M shares
of 106M outstanding shares and own 45.66% of the company stock.
Largest 10 shareholders include EcoR1 Capital, LLC (5.12M shares), BlackRock Inc. (4.2M shares), Alphabet Inc. (4.1M shares), PFM Health Sciences, LP (3.43M shares), BVF INC/IL (3.23M shares), FMR LLC (3.09M shares), VANGUARD GROUP INC (2.47M shares), STATE STREET CORP (2.33M shares), BOXER CAPITAL, LLC (2.08M shares), and Invus Financial Advisors, LLC (1.84M shares).
This table shows the top 127 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.